The present data indicating that p140Cap is a new player in the regulation of plasma membrane fluidity, may add a further layer of complexity to the stratification of TNBC, where the levels of p140Cap may be used as clinical biomarker for tumor aggressiveness. Here, SRCIN1 is linked to neoplasm.